BRAF V600E and Molecular Testing in Anaplastic Thyroid Cancer: A Patient Guide to Precision Treatment
BRAF V600E anaplastic thyroid cancer testing can reveal an important molecular treatment target and help guide precision treatment decisions. This comprehensive patient guide explains BRAF V600E, DNA and RNA molecular testing, NGS reports, targeted therapy, dabrafenib and trametinib, treatment resistance, BRAF-negative ATC, surgery after targeted therapy, liquid biopsy and carefully coordinated integrative supportive care.